ReviewFrontiers in pharmacology2023

Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review.

Qiang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.